NCT Number: NCT02235142
Prostatic Cancer Versus Androgen Deficiency
Open study to make a comparison between hypogonadism and euogonadism patients regarding the severity of prostate cancer. The purpose of this study is to determine the importance of the relationship between the hormonal status and the type of the tumor at the time of surgical intervention as well as follow up of the patients.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
Male
Study type
Interventional
Phase
Not applicable
Primary location
Hôpital Foch, Suresnes, Île-de-France Region, France
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Male patients over than 18 years of age, with localized, stage I or II prostate cancer, not receiving local treatment (radiation, phototherapy, thermotherapy,…) or hormonal therapy, showing indication of radical prostatectomy.
Exclusion criteria
- Absence of radical prostatectomy indication
- Patient received local or hormonal therapy prior to surgery
- Patients already enrolled in other clinical study incompatible with the study
- Patients on a treatment which can affect hormonal level (Prednisone, Ketoconazole, Abiraterone, Finasteride, Dutasteride)
Treatment and study plan
Primary outcomes
-
Testosteron Serum level
Time frame: The day prior to surgery
-
Gleason score
Time frame: 5 years
Sponsors and collaborators
Lead sponsor
Hopital Foch
Other
Registry information
Official study title
Localised Cancer of Prostate and Androgen Deficiency.
Acronym: AndroCan
Important dates
- Study start
- 2013
- Primary completion
- 2016
- Study completion
- 2021
- First posted
- Sep 9, 2014
- Registry last updated
- Jan 20, 2022
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy
NCT03388619
Cancer Of Prostate, Genital Diseases
Bethesda, Maryland, United States
View Trial DetailsAssessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer Foci
NCT01639859
Cancer Of Prostate, Genital Diseases
Lyon, LYON, France
View Trial DetailsLong-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139
NCT02362464
Cancer Of Prostate, Genital Diseases
Bethesda, Maryland, United States
View Trial DetailsDe-implementation of Low Value Castration for Men With Prostate Cancer
NCT03579680
Cancer Of Prostate, Genital Diseases
Ann Arbor, Michigan, United States
View Trial Details